Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00374842
Status:
COMPLETED
Last Update Posted:
2018-06-08
First Post:
2006-09-08
Brief Title:
Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline GSK Biologicals GSK1247446A Low Dose Influenza Vaccine Candidate
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline